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action of UFH in vitro. In light of these results, a reevaluation of UFH dosing in combina- 
tion with each individual fibrin specific thrombolytic agent used for AMI is warranted in the 
clinical setting. 
1192-34 Grat ing  o f  Three-d imens iona l  Co l lagen  Type 1 Sca f fo ld  
on Injured Myocardium Induces Neovascularizatlon and 
Improves Cardiac Function 
Mohamed A. Gaballa, Joseph Bahl, Eugene Morkin, Steven Goldman, University of 
Arizona, Tucson, Arizona, SAVAHCS, Tucson, Arizona. 
Grating cells into cardiac muscle has been proposed used as a potential mechanism for 
augmenting cardtomyocyte numbers in the adult heart. The fate and effect of engrafting 
fetal cells into infarcted hearts remains unclear. One approach to overcoming this limita- 
tion is to graft a naturally modified extrecellular matrix (collagen-1) scaffold onto the myo- 
cardium. We found, three-weeks after grafting, the 3-D collagen scaffold was integrated 
completely with the cryo-injured myocardium. The scaffold prevented LV dilation. At zero 
left ventricular (LV) pressure, the LV lumen diameter and the outer diameter measured at 
the equator were decreased from 11041±212 to 9144_+135 mm, and 13469 ±187 to 
11673 ±104, N=4, respectively). The scaffold improved cardiac function by shifting of the 
LV pressure-volume curve to the left toward control. It induced neoangiogeneeis with the 
graft (10 neovessel per 40x field versus zero), with the new vessels connected to native 
coronary vasculature in the noninfarcted myocardium. In addition, this neovascularization 
was associated with recruitment of endothelial progenitor stem cells, CD34 +. When com- 
pared to the infarcted rats, hemodynamics parameters measured at 3-wks after scaffold 
grafting were not different. Thus, this study shows that grafting 3-D collagen-1 scaffold 
onto an injured myocardium integrates with the tissue, allows for cell growth and differen- 
tiation, induces mature vessel formation within the graft, and results in improved cardiac 
diastolic function by preventing LV dilation. 
1192-35 80-Lead Body Map Detects Acute ST Elevation 
Myocardial Infarction Missed by Standard 12-Lead 
Electrocardiography 
Joseoh P. Ornato, lan B. Menown, John W. Riddell, Simon Carley, Kevin Mackway- 
Jones, George L. Higgins, ill, Mary Ann Peberdy, Michael C. Kontos, Suzanne J. 
Maynard, A.A. Jennifer Adgey, for the PRIME Investigators, Virginia Commonwea/th 
Universi~ Richmond, Virginia. 
Background: We conducted a multicanter clinical trial to determine whether an 80-1eed 
PRIME-ECG body map system (PRIME) could detect more acute ST-segment elevation 
MIs (STEMI) than standard 12-lead ECGs (ECG) in chest pain patients presenting to 4 
hospital EDs (Virginia Commonwealth University, Richmond, VA; Manchester Royal Infir- 
mary, Manchester, England; Maine Medical Center, Portland, ME; Royal Victoria Hospi- 
tal, Belfast, Northern Ireland). 
Methods: A trained technician performed an ECG and PRIME on all consenting adult ED 
chest pain patients in whom MI or ischemia was considered clinically. Sensitivity and 
specificity of each test for detecting STEMI was calculated using 3 different MI defini- 
tions, all of which required diagnostic ST elevation on either ECG or PRIME plus: 1) ele- 
vated CKMB (CKMB-MI); 2) elevated troponin (TROP-MI); or 3) a clinical discharge 
diagnosis of acute MI (CLIN-MI). 
Results (Table): 
The MI locations most commonly missed by ECG but detected by PRIME were: 1) 
CKMB-MI: 1 septal, 4 posterior (1 infero-post), 1 inferior; 2) CLIN-MI: 1 septal, 8 posterior 
(3 infero-post), 1 inferior; and 3) TROP-MI: 2 septal, 9 posterior (3 infero-post), 1 inferior. 
The incidence of extensive right ventricular involvement diagnosable only by PRIME in 
inferior STEMI was: CKMB-MI 2/9 (22%), TROP-MI 2/9 (22%), CLIN-MI 6/18 (33%). 
Conclusions: 
PRIME is more sensitive for detecting STEMI than ECG, but has similar specificity. Pos- 
terior MIs are most commonly missed by ECG but detected by PRIME. 
N ECG PRIME p ECG PRIME p 
sensitivity sensitivity specificity specificity 
CKMB-MI 22/365 72.7% 100% .02 97.1% 96.5% ns 
TROP-MI 28/225 57.1% 92.9% .008 96.5% 94.9% ns 
CLIN-MI 41/647 75.6% 90.2% .09 98.0% 96.7% ns 
1192-36 Rest Myocardial Perfusion Imaging Results in Patients 
With Troponin I Elevations 
Michael C. Kontos. Melvin J. Fratkin, Robed L Jesse, Joseph P. Ornato, James L. 
Tatum, MCV/VCU, Richmond, Virginia. 
Background: Myocardial perfusion imaging (MPI) is used often to identify patients (pts) 
with myocardial infarction (MI). Its diagnostic accuracy in pts with smaller amounts of 
damage as assessed by troponin, has not been well studied. Methods: Pts considered 
low risk for MI underwent rest gated tomographic MPI and serial marker assessment 
(CK, CK-MB and Tnl) as part of standard chest pain evaluation protocol. Pts with Tnl ele- 
vations were analyzed further for this study. MI was defined as CK-MB>8 ng/mL. MPI 
was considered positive if there was a perfusion defect in association with abnormal wall 
motion or thickening. Short axis images were divided into 17 segments and graded on a 
4 point scale (0 normal, 3 high grade or absent perfusion) and a summed defect score 
(SDS) was derived. Results: A total of 214 pts had MPI and Tnl elevations, of whom 93 
(39%) did not meet CK-MB MI criteria. MPI was positive in 181 (75%) including 63% of 
Tnl positive but CK-MB MI negative pts. Pts with positive MPI had a mean 2.6-+1.3 seg- 
ments abnormal and a mean SDS of 6.1±3.7. Pts with negative MPI had smaller MIs 
(peak CK-MB 18.-:23 vs 43±66 ng/mL, p<0.001), and were more likely to have non-signif- 
icant coronary disease on angiography (37% vs 17%, p<0.05) than those with positive 
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MPI. Higher SDS was associated with larger MIs as estimated by peak CK-MB and CK 
(Table). Conclusions: MPI and Tnl offer complementary data for assessing pts with pos- 
sible MI. Pts with ne~iative MPI have small MIs and less extensive coronary disease. 
SOS 0 1-3 4-6 7-9 > 10 
% In Each Group 25 17 26 14 11 
Median Peak CK-MB, ng/ml 7.2 16 20 31 43 
Median Peak CK, U/L 186 263 383 383 572 
11 92-37 Infarct Size Limitation by Gene Transfer of Baculoviral 
P35 Into Rat Myocardlum 
Lorenz Bott-Flueoel. Karl-Ludwig Laugwitz, Melchior Seyfarth, Chdstiane Faltermeier, 
Christine Baumgartner, Alessandre Moretti, Albert Schoemig, Deutsches Herzzentrum, 
Muenchen, Germany,/. Meal. K/inik, Klinikum Rechfs der Isar, Muenchen, Germany, 
Background: Apoptosis plays a pivotal role in determining the extent of injury during 
myocardial infarction. Inhibition of apoptosis has been shown to protect myocardium from 
damage during ischemia and reperfusion. The aim of this study was to determine 
whether gene transfer of baculoviral protein p35, a potent inhibitor of apoptosis, into myo- 
cardium could limit infarct size. Methods: Male Wistar rats were directly injected into the 
left antedor walt with adenoviral vector encoding baculoviral p35. 72 hours later hearts 
were mounted on a Langendorff apparatus and perfused. The left antedor descending 
coronary artery was ligatad for 30 minutes and reperfused for 2 hours. Area at risk and 
infarct size were determined by staining with bromophenolblue and triphenoltetrezolium- 
chloride ('I-I'C), respectively. Apoptosis was measured by assessing the DNA-laddering, 
and by in-situ staining for DNA-strand breaks (TUNEL-assay) and active caspass-3. 
Results: Infarct size was significantly reduced in animals treated with p35 (59 +/- 3 % 
reduction, p<0.05), whereas no reduction was seen when only control vector was 
injected. Apoptosis was diminished significantly only in animals treated with p35. Con- 
clusion: Gece transfer of the baculovirel protein p35 into the left vantricular myocardium 
diminishes caspase-3 activity and thereby reduces infarct size after regional ischemia 
and reperfusion. 
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1193-27 Comparat ive  Analyses of the Prognostic Value of Novel 
Cardiac Markers In Patients With Non-ST Elevation 
Acute Coronary Syndromes 
Oscar Bazzino. Jos~ L. Navarro Estrada, Femando Botto, Maria I. Sosa Liprandi, Juan J. 
Fuselli, Jos~ Santopinto, Rodolfo Ahuad, Roberto Norclaby, Simdn Saiszberg, Alfredo 
Hirschson Prado, Jos~ Gant Lbpez, Mario Russo, Fernando Sokn, Mamelo P(~rez, 
Cados Bruno, PACS /nvestigators, Buenos Aires, A~entina. 
Background: Cardiac markers have different release characteristics, sensitivity and spec- 
ificity. A multi-marker strategy testing for prognostic markers may improve risk stratifica- 
tion in patients (pts) with non-ST-elevation acute coronary syndromes (NSTACS) 
Methods: This prospective multicanter cohort study included 1000 consecutive pts admit- 
ted with NSTACS. Baseline clinical and electrocardiographic data were recorded. Single 
assays of 3rd generation troponin T(TnT), high sensitivity C-reactive protein (CRP) and 
myoglobin (Myo), were performed after 9 hours (median) from symptom onset. Results 
were kept blinded until the end of the study. The association between markers and 180 
day events was examined by chi-squara and logistic regression analyses. The primary 
endpoint was the 180-day incidence of death or myocardial infarction (D/AMI). Results: 
D/AMI occurred in 9.4% of pts at 180 days. Prognostic values of total CK (upper normal 
value x2),TnT (>0.01ng/ml), CRP (>3 mg/I)and Myo (>80 ng/ml),were: 
180 day D/AMI 
n ER(%) OR 95%CI S Sp PPV NPV 
CRP>0.3 mg/I 602 12.0 2.2 1.3-3.6 75.7 41.4 12.0 94.2 
TnT>0.01 ng/ml 428 15.2 3.2 2.0-5.0 68.4 59.9 15.2 94.8 
Myo>80 ng/ml 243 18.9 3.3 2.2-5.2 48.4 78.2 18.9 93.5 
Total CK x 2 138 20.3 3.0 t .8-5.9 29.5 87.8 20.3 92.2 
ER: Event Rate, S: sensitivity, Sp: specificity, PPV: positive predictive value, NPV: neg- 
ative predictive value, OR: odds ratio 
By regression analyses, total CK was not an independent predictor. The TnT-only model 
significantly improved by adding Myo and CRP data (delta chi-square:20.03, p=0.006). 
Conclusions: In a non selected population of NSTACS, a model including 4 cardiac 
markers showed that TnT, Myo and CRP are independent predictors of adverse out- 
come. Total CK has not additional prognostic value on top of TnT, Myo and CRP.A combi- 
nation of these markers may assist to identify the pts at increased risk of future events. 
